ロード中...

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel

BACKGROUND: Anti-CD19 CAR T cell therapy has demonstrated high response rates in patients with relapsed or refractory (r/r) B cell malignancies but is associated with significant toxicity. Cytokine release syndrome (CRS) is the most significant complication associated with CAR T cell therapy, and it...

詳細記述

保存先:
書誌詳細
出版年:J Hematol Oncol
主要な著者: Porter, David, Frey, Noelle, Wood, Patricia A., Weng, Yanqiu, Grupp, Stephan A.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833070/
https://ncbi.nlm.nih.gov/pubmed/29499750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-018-0571-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!